Search by Drug Name or NDC

    NDC 51655-0120-52 Glimepiride 4 mg/1 Details

    Glimepiride 4 mg/1

    Glimepiride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals, LLC. The primary component is GLIMEPIRIDE.

    Product Information

    NDC 51655-0120
    Product ID 51655-120_f2b3e5d4-8ae1-acfc-e053-2a95a90a4b30
    Associated GPIs 27200027000340
    GCN Sequence Number 025181
    GCN Sequence Number Description glimepiride TABLET 4 MG ORAL
    HIC3 C4K
    HIC3 Description ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE
    GCN 05833
    HICL Sequence Number 010485
    HICL Sequence Number Description GLIMEPIRIDE
    Brand/Generic Generic
    Proprietary Name Glimepiride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Glimepiride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/1
    Substance Name GLIMEPIRIDE
    Labeler Name Northwind Pharmaceuticals, LLC
    Pharmaceutical Class Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078181
    Listing Certified Through 2024-12-31

    Package

    NDC 51655-0120-52 (51655012052)

    NDC Package Code 51655-120-52
    Billing NDC 51655012052
    Package 30 TABLET in 1 BOTTLE, DISPENSING (51655-120-52)
    Marketing Start Date 2014-12-29
    NDC Exclude Flag N
    Pricing Information N/A